Clinical trial
Respiratory Immune Responses in Human Influenza Virus Infection Across Age to Understand What Dictates Disease Severity
NCT06401720 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Respiratory Immune Responses in Human Influenza Virus Infection Across Age to Understand What Dictates Disease Severity
- Lead sponsor
- Karolinska Institutet
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- January 1, 2024
- Completion date
- December 31, 2030
- Enrollment
- 800 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
influenza a infection, influenza b virus infection, rsv infection, sars cov 2 infection